Precision Biosciences Inc. (DTIL)
NASDAQ · Healthcare
Precision Biosciences Inc. EBITDA 2018–2025
Precision Biosciences Inc. annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Precision Biosciences Inc. ebitda for the quarter ending March 31, 2026 was -8.8 M, a 59.59% decrease year-over-year.
- Precision Biosciences Inc. ebitda for the twelve months ending March 31, 2026 was -44.9 M, a 47.64% decrease year-over-year.
- Precision Biosciences Inc. annual ebitda for 2025 was -50.7 M, a 122.69% increase from 2024.
- Precision Biosciences Inc. annual ebitda for 2024 was -22.8 M, a 38.36% decrease from 2023.
- Precision Biosciences Inc. annual ebitda for 2023 was -36.9 M, a 32.27% decrease from 2022.
- Precision Biosciences Inc. annual ebitda for 2022 was -54.5 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Precision Biosciences Inc. EBITDA — FAQ
Precision Biosciences Inc. (DTIL) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DTIL's ebitda history?
The chart and table above show Precision Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.